Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

Abstract Background Rifampicin-resistant tuberculosis (RR-TB) remains an important global health problem. Ideally, the complete drug-resistance profile guides individualized treatment for all RR-TB patients, but this is only practised in high-income countries. Implementation of whole genome sequenci...

Full description

Bibliographic Details
Main Authors: Annelies Van Rie, Elise De Vos, Emilyn Costa, Lennert Verboven, Felex Ndebele, Tim H. Heupink, Steven Abrams, SMARTT team, Boitumelo Fanampe, Anneke Van der Spoel Van Dyk, Salome Charalambous, Gavin Churchyard, Rob Warren
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Trials
Subjects:
Drug resistance
Tuberculosis
Whole-genome sequencing
Clinical trial
Pragmatic
Strategy trial
Online Access:https://doi.org/10.1186/s13063-022-06793-w

Internet

https://doi.org/10.1186/s13063-022-06793-w

Similar Items